Double immune attack: new combo therapy targets tough lymphoma
NCT ID NCT07542678
First seen May 03, 2026 · Last updated Jun 13, 2026 · Updated 8 times
Summary
This phase 2 trial tests a new treatment strategy for people with a fast-growing blood cancer (large B-cell lymphoma) that has come back or not responded to standard therapy. The approach uses two immune-based treatments: a drug called glofitamab given before and after standard CAR-T cell therapy. The goal is to see if this combination improves the chance of complete remission in 20 high-risk patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RELAPSED /REFRACTORY DLBCL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Charité - Universitätsmedizin Berlin - Campus Benjamin Franklin
Berlin, State of Berlin, 12203, Germany
Contact
-
Universitätsklinikum Düsseldorf - Klinik für Hämatologie, Onkologie und klinische Immunologie
Düsseldorf, North Rhine-Westphalia, 40225, Germany
Contact
-
Universitätsklinikum Essen (AöR) - Westdeutsches Tumorzentrum Essen - Klinik für Hämatologie und Stammzellltransplantation
Essen, North Rhine-Westphalia, 45147, Germany
Contact
-
Universitätsklinikum Heidelberg - Innere Medizin V
Heidelberg, Baden-Wurttemberg, 69120, Germany
Contact
-
Universitätsklinikum Münster - Medizinische Klinik A
Münster, North Rhine-Westphalia, 48149, Germany
Contact
Conditions
Explore the condition pages connected to this study.